Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Funding to advance AI-native drug R&D engine and pipelines, including MDR-001, an oral GLP-1 small-molecule in Phase III clinical trials in China.
-
Austin, TX, USA, July 01, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Human Fibrinogen Concentrate Market Size, Trends and Insights By Form...
-
Regulatory approvals, strategic acquisitions, clinical development milestones, and financing initiatives are highlighting continued activity across the bio
-
New Autism Research to be Presented at European Purine Scientific Meeting by Marvel Biosciences Collaborators at iBrain Institute in Tours France
-
CTA Approval from Germany's Federal Institute for Drugs and Medical Devices (BfArM), accompanied by a positive opinion from the Ethics Committee of the North Rhine Medical Association, clears Silexion...
-
NeOnc’s (NASDAQ: NTHI) recent Abu Dhabi IND authorization for NEO212 highlights an increasingly attractive pharmaceutical industry development strategy
-
Austin, TX, USA, June 18, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Fluorescent In Situ Hybridization Probe Market Size, Trends and Insights By...
-
Austin, TX, USA, June 17, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “GLP-1 Receptor Agonist Market Size, Trends and Insights By Product Type...
-
Grand Cayman, June 16, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for...
-
CleveMed has joined Beacon Biosignals to advance what is possible in at-home sleep diagnostics.